Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
2022-02-15 21:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
2022-02-15 21:00
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)
2022-02-15 16:00
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases
2022-02-15 15:05
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI
2022-02-15 09:30
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
2022-02-14 17:34
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent
2022-02-14 08:25
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio
2022-02-14 08:00
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries
2022-02-13 18:30
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results
2022-02-12 06:05
Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients
2022-02-11 20:40
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
2022-02-11 10:45
FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission
2022-02-11 10:44
Alphamab Oncology Announced IND Approval of PD-L1/OX40 Bispecific Antibody KN052
2022-02-11 09:31
Ucello Therapeutics Completes US$25 Million Series A Financing
2022-02-11 02:16
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
2022-02-10 20:00
AKESO'S NGF MONOCLONAL ANTIBODY (AK115) APPROVED TO INITIATE CLINICAL TRIAL IN PAIN (INCLUDING CANCER PAIN)
2022-02-10 17:00
GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability
2022-02-10 16:34
TABERNACLE HEALTH GROUP LAUNCHES CHINESE PROPRIETARY MEDICINE, AVROCIL (TM) COLD AND FLU AID
2022-02-10 15:17
Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
2022-02-10 08:21
1
199
200
201
202
203
420